A detailed history of Abound Wealth Management transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Abound Wealth Management holds 8 shares of CORT stock, worth $476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 12 33.33%
Holding current value
$476
Previous $390,000 4.87%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$29.51 - $46.26 $118 - $185
-4 Reduced 33.33%
8 $371,000
Q2 2023

Aug 08, 2024

BUY
$21.44 - $25.15 $257 - $301
12 New
12 $267,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.38B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.